Port Hueneme’s Stellar Biotechnologies posts mixed earnings results
Stellar Biotechnologies saw revenues increase 130 percent during the first quarter of 2016 but the company still lost more money in 2016 than it did during the same quarter of 2015. The Port Hueneme-based company reported first quarter 2016 results after markets closed Feb. 8. Stellar makes a protein for immunotherapy treatments using a unique Read More →
Read More →Port Hueneme’s Stellar Biotechnologies trading on Nasdaq
Port Hueneme-based Stellar Biotechnologies started trading on the Nasdaq stock exchange Nov. 5. Stellar makes a protein for immunotherapy treatments using a unique sea snail only found off the coastal shores of a small part of California. Shares opened at $8.74 on Nov. 5 and were trading on the Nasdaq at $9.40 as of 11:30 Read More →
Read More →
Navy program at Port Hueneme taps area companies for new technology
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →
Sponsored content:
2015-2016 Giving Guide
